Exagen Inc.

Exagen Inc. - Enterprise Valueverified

XGN

Price:

$7.87

Market Cap:

$190.14M

Exagen Inc. develops and commercializes diagnostic testing solutions, leveraging its proprietary cell-bound complement activation products (CB-CAPs) technology under the AVISE brand throughout the United States. The company's mission is to equip rheumatologists with advanced tools for the precise diagnosis, prognosis, and ongoing management of autoimmune and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its flagship product, AVISE CTD, aids in distinguishing between various connective tissue diseases (CTDs) and other conditions with overlapping symptoms in symptomatic patients. The company's product portfolio includes AVISE Lupus, which assesse...[Read more]

Industry

Medical - Diagnostics & Research

IPO Date

2019-09-19

Stock Exchange

NASDAQ

Ticker

XGN

The Enterprise Value as of September 2026 (TTM) for Exagen Inc. (XGN) is 191.10M

According to Exagen Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 191.10M. This represents a change of 36.74% compared to the average of 139.75M of the last 4 quarters.

Exagen Inc. (XGN) Historical Enterprise Value (quarterly & annually)

How has XGN Enterprise Value performed in the past?

The mean historical Enterprise Value of Exagen Inc. over the last ten years is 80.61M. The current 191.10M Enterprise Value has changed 23.61% with respect to the historical average. Over the past ten years (40 quarters), XGN's Enterprise Value was at its highest in in the December 2019 quarter at 273.04M. The Enterprise Value was at its lowest in in the September 2019 quarter at -28532702.39.

Quarterly (TTM)
Annual

Average

80.61M

Median

50.18M

Minimum

8.77M

Maximum

273.06M

Exagen Inc. (XGN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Exagen Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.05%

Maximum Annual Enterprise Value = 273.06M

Minimum Annual Increase = -87.93%

Minimum Annual Enterprise Value = 8.77M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025124.56M64.32%
202475.80M245.81%
202321.92M58.75%
202213.81M-87.93%
2021114.38M-16.22%
2020136.53M-50.00%
2019273.06M2.05%
201812.70M44.94%
20178.77M-64.31%
201524.56M64.18%

Exagen Inc. (XGN) Average Enterprise Value

How has XGN Enterprise Value performed in the past?

The current Enterprise Value of Exagen Inc. (XGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

74.09M

5-year avg

70.09M

10-year avg

80.61M

Exagen Inc. (XGN) Enterprise Value vs. Peers

How is XGN’s Enterprise Value compared to its peers?

Exagen Inc.’s Enterprise Value is less than NeoGenomics, Inc. (813.90M), greater than MDxHealth S.A. (121.14M), less than Aclaris Therapeutics, Inc. (735.02M), greater than Stereotaxis, Inc. (121.02M), less than Sanara MedTech Inc. (354.68M), less than Sight Sciences, Inc. (401.85M), less than Alpha Teknova, Inc. (420.83M), less than BioAge Labs Inc. (233.46M), less than Lifecore Biomedical, Inc. (305.12M), less than Vanda Pharmaceuticals Inc. (274.24M),

CompanyEnterprise ValueMarket cap
813.90M$511.07M
121.14M$34.50M
735.02M$754.18M
121.02M$126.33M
354.68M$321.57M
401.85M$439.63M
420.83M$399.42M
233.46M$304.59M
305.12M$167.29M
274.24M$307.29M

Build a custom stock screener for Exagen Inc. (XGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Exagen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Exagen Inc. (XGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Exagen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Exagen Inc.'s Enterprise Value?

What is the highest Enterprise Value for Exagen Inc. (XGN)?

What is the 3-year average Enterprise Value for Exagen Inc. (XGN)?

What is the 5-year average Enterprise Value for Exagen Inc. (XGN)?

How does the current Enterprise Value for Exagen Inc. (XGN) compare to its historical average?